EichorEICHOR
Location: Leeuwarden Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Leeuwarden

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0031 · Bristol-Myers Squibb · NCT07106762This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Frisius Medisch Centrum · Pfizer · NCT06758401Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Frisius Medisch Centrum, locatie Leeuwarden · Amgen · NCT07037433No Guts No Glory Probiotics
Phase 2/Phase 3 · KieN VIP Leeuwarden · University Medical Center Groningen · NCT07606014Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Medical Center Leeuwarden · Maastricht University Medical Center · NCT04486495A Study With CIT-013 in RA Patients
Phase 2 · NL-05 · Citryll BV · NCT06567470A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Frisius Medisch Centrum ( Site 1702) · Merck Sharp & Dohme LLC · NCT06623422Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Medisch Centrum Leeuwarden · Daiichi Sankyo · NCT06731478A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Frisius Medisch Centrum · Pfizer · NCT06629779The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · Frisius MC · Alzheimercentrum Amsterdam · NCT07680335Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · Medisch Centrum Leeuwarden · Catharina Ziekenhuis Eindhoven · NCT05405270DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass
NA · Medisch Centrum Leeuwarden · St. Antonius Hospital · NCT04894838A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · Frisius Medisch Centrum ( Site 4808) · Merck Sharp & Dohme LLC · NCT07513376National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Phase N/A · Medisch Centrum Leeuwarden · PROspective Renal Cancer Cohort Foundation · NCT05326620S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System
Phase N/A · Medical Center Leeuwarden · Sahajanand Medical Technologies Limited · NCT03443999A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Frisius Medisch Centrum · Eli Lilly and Company · NCT06119581Prospective Data Collection Initiative on Thoracic Malignancies
Phase N/A · Frisius MC · Dutch Society of Physicians for Pulmonology and Tuberculosis · NCT06996249Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
Phase 4 · Medical Center Leeuwarden MCL · R.Bos · NCT04985435Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH)
NA · Medisch Centrum Leeuwarden · Isala · NCT06342843Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study
NA · GGZ Friesland · Maastricht University · NCT05812950Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Phase 4 · Medisch Centrum Leeuwarden · Leiden University Medical Center · NCT06172010The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Frisius Medical Center · University of Leicester · NCT04204915Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Medische Centrum Leeuwarden ( Site 1172) · Merck Sharp & Dohme LLC · NCT06136624Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal Cancer
Phase N/A · Medisch Centrum Leeuwarden · University Medical Center Groningen · NCT03941080Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Phase 2 · Frisius MC Leeuwarden, Hart- en Vaatcentrum · Acesion Pharma · NCT07267949Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis
Phase N/A · Medisch Centrum Leeuwarden · Franciscus Gasthuis · NCT06845332Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction
Phase 2 · Frisius medisch centrum · Erasmus Medical Center · NCT06161818AFT: Introduction of a Full Breast Reconstructive Method
Phase N/A · Medical Center Leeuwarden · Maastricht University Medical Center · NCT04261829Prospective Bladder Cancer Infrastructure (ProBCI)
Phase N/A · Medisch Centrum Leeuwarden · Prospective Bladder Cancer Infrastructure Foundation · NCT04503577REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Phase 2 · NL-Leeuwarden-MCL · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT04523428
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.